Current Practices and Risk Assessment in COVID-19 Vaccine Procurement in Nigeria

• DOI: 10.55640/ijmsdh-10-01-06
• Publication Date: 2024-01-29T05:21:00Z
• Authors: Emma Akpan; Chris Elemuwa Ele...; ; Irene Esu; ; Uchenna Elemuwa; ; Tochukwu Elemuwa; ; Vivian Onukwuli; ; Nne Pepple; ; Victoria Ukoh; ; Josephine Omo-Emm...; ; Andrew Anyakwo

The global battle against the COVID-19 pandemic has underscored the critical challenge of procuring and managing vaccines. This study delves into the Nigerian context, specifically within the framework of the Primary HealthCare Development Agency, to comprehensively explore the nuanced aspects of COVID-19 vaccine procurement. The primary objective is to elucidate current procurement practices, examining diverse sources, methods, and key stakeholders involved in the process. The analysis thoroughly evaluates potential risks, including corrupt policies, high costs, inadequate storage capacity, delayed deliveries, substandard and falsified vaccines, and unreliable implementation strategies. Delving into the intricate factors influencing these risks, the study utilizes correlation matrix and regression analysis to underscore the implications of key variables, emphasizing the imperative need for targeted interventions in COVID-19 vaccine procurement practices. Positioned as a timely resource in the dynamic field of public health, this research advocates for continuous collaboration, innovation, and strategic planning to fortify the resilience of the vaccine procurement and supply system.